India’s leading vaccine innovator Bharat Biotech has announced the establishment of a Contract Research, Development, and Manufacturing Organization (CRDMO) division dedicated to cell and gene therapy, marking a strategic expansion into one of the most advanced frontiers in biomedical science. The new CRDMO arm will focus
Apollo AyurVAID, India’s leading chain of precision Ayurveda hospitals and a pioneer in integrative medicine, today signed a Memorandum of Understanding (MoU) with the Jawaharlal Nehru Tropical Botanic Garden and Research Institute (JNTBGRI), an autonomous R&D institution under the Kerala State Council for Science, Technology
Granules India Limited (BSE: 532482, NSE: GRANULES) today announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss-based CDMO specializing in peptides. Senn develops and manufactures, Peptides and Peptides based applications for its global customers, providing contract research, development, and manufacturing services.
Study Synopsis In patients classified as HBR, there was a significant reduction in the primary endpoint (p=0.043) when comparing physiology-guided complete revascularization to the culprit-only strategy. The study was conducted across 34 participating sites spanning Italy, Spain, and Poland covering 1445 patients from July
